Abatacept - Latest Advances

Burden of Disease and Drug Response for Patients with Rheumatoid Arthritis by Shared Epitope and Anti-Citrullinated Protein Antibody Status.

Journal: The Journal of rheumatology

Published: October 15, 2025

Autoimmunity in Patients with CTLA-4 Haploinsufficiency

Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Published: October 02, 2025

Partial Response to Abatacept for Bilateral Asymmetrical Intermediate Uveitis in CTLA-4 Haploinsufficiency.

Journal: Ocular immunology and inflammation

Published: September 23, 2025

Comparison of utilization and total medicare fee-for-service expenditures for subcutaneous versus intravenous versions of a select group of therapies.

Journal: Journal of medical economics

Published: September 12, 2025

Peripheral blood or bone marrow grafts for mismatched unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis.

Journal: Transplantation and cellular therapy

Published: September 05, 2025

Tailoring of Immunosuppression With Belatacept in De Novo and Conversion Settings and Risk Mitigation Strategies.

Journal: Transplantation

Published: September 03, 2025

Anti-CTLA-4 Treatment Abrogates Co-stimulation Blockade-induced Acceptance of Transgenic Porcine Islets in Humanized Mice.

Journal: Transplantation

Published: August 26, 2025

Multiple Organ Involvement in a Boy with Lipopolysaccharide-Responsive Beige-like Anchor Protein Deficiency Detected by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Journal: Pediatric allergy, immunology, and pulmonology

Published: August 18, 2025

Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy.

Journal: International journal of molecular sciences

Published: August 18, 2025

Retraction Note: CTLA4-Ig alleviates the allogeneic immune responses against insulin-producing cells in a murine model of cell transplantation.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: August 14, 2025

Targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies.

Journal: The Cochrane database of systematic reviews

Published: August 01, 2025

Treatment of Persons with Rheumatoid Arthritis with a History of Cancer.

Journal: Current rheumatology reports

Published: July 30, 2025

Filters

Burden of Disease and Drug Response for Patients with Rheumatoid Arthritis by Shared Epitope and Anti-Citrullinated Protein Antibody Status.

Burden of Disease and Drug Response for Patients with Rheumatoid Arthritis by Shared Epitope and Anti-Citrullinated Protein Antibody Status.

Autoimmunity in Patients with CTLA-4 Haploinsufficiency

Autoimmunity in Patients with CTLA-4 Haploinsufficiency

Partial Response to Abatacept for Bilateral Asymmetrical Intermediate Uveitis in CTLA-4 Haploinsufficiency.

Partial Response to Abatacept for Bilateral Asymmetrical Intermediate Uveitis in CTLA-4 Haploinsufficiency.

Comparison of utilization and total medicare fee-for-service expenditures for subcutaneous versus intravenous versions of a select group of therapies.

Comparison of utilization and total medicare fee-for-service expenditures for subcutaneous versus intravenous versions of a select group of therapies.

Peripheral blood or bone marrow grafts for mismatched unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis.

Peripheral blood or bone marrow grafts for mismatched unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis.

Tailoring of Immunosuppression With Belatacept in De Novo and Conversion Settings and Risk Mitigation Strategies.

Tailoring of Immunosuppression With Belatacept in De Novo and Conversion Settings and Risk Mitigation Strategies.

Anti-CTLA-4 Treatment Abrogates Co-stimulation Blockade-induced Acceptance of Transgenic Porcine Islets in Humanized Mice.

Anti-CTLA-4 Treatment Abrogates Co-stimulation Blockade-induced Acceptance of Transgenic Porcine Islets in Humanized Mice.

Multiple Organ Involvement in a Boy with Lipopolysaccharide-Responsive Beige-like Anchor Protein Deficiency Detected by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Multiple Organ Involvement in a Boy with Lipopolysaccharide-Responsive Beige-like Anchor Protein Deficiency Detected by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy.

Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy.

Retraction Note: CTLA4-Ig alleviates the allogeneic immune responses against insulin-producing cells in a murine model of cell transplantation.

Retraction Note: CTLA4-Ig alleviates the allogeneic immune responses against insulin-producing cells in a murine model of cell transplantation.

Targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies.

Targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies.

Treatment of Persons with Rheumatoid Arthritis with a History of Cancer.

Treatment of Persons with Rheumatoid Arthritis with a History of Cancer.